Fitbit Data Reveals Declining Sleep Quality and Activity in Pulmonary Hypertension
Year-long wearable device study shows PAH patients experience worsening sleep stages and reduced daily steps compared to healthy controls.
Summary
Researchers tracked 110 pulmonary arterial hypertension (PAH) patients using Fitbit devices for 12 weeks, with 44 patients monitored again after one year. PAH patients averaged 5,200 daily steps at baseline, correlating strongly with 6-minute walk test performance. Over one year, daily steps declined to 4,651 while sleep quality deteriorated significantly compared to matched healthy controls. The study demonstrates wearable devices can objectively monitor disease progression in PAH patients outside clinical settings.
Detailed Summary
This groundbreaking study represents the first longitudinal analysis of sleep and activity patterns in pulmonary arterial hypertension (PAH) using consumer wearable devices. Researchers from Vanderbilt and other major medical centers tracked 110 PAH patients using Fitbit devices for 12 weeks, with 44 patients completing follow-up monitoring after one year.
The baseline findings revealed strong correlations between wearable-derived metrics and established clinical measures. Average daily steps correlated significantly with 6-minute walk distance (r=0.61, p<0.001), validating wearables as meaningful functional assessments. Patients averaged 5,200 steps daily at baseline, substantially lower than typical healthy adults. Sleep analysis showed concerning patterns, with REM sleep percentage correlating with daily activity levels (r=0.28, p=0.008).
The longitudinal results demonstrated clear disease progression over one year. Daily steps declined significantly from 5,200 to 4,651 (p=0.008), representing a 10.6% decrease in physical activity. More striking were the sleep quality changes when compared to 132 matched healthy controls from the All of Us Research Program. PAH patients showed significant group-time interactions for light sleep percentage (p=0.024) and REM sleep percentage (p=0.034), indicating their sleep architecture deteriorated relative to controls.
These findings have important clinical implications. Unlike the 6-minute walk test performed in controlled clinic settings, wearable devices capture real-world functional capacity over extended periods. The correlation between daily steps and established functional measures suggests wearables could serve as continuous monitoring tools for disease progression. The sleep data provides the first objective, longitudinal evidence of sleep quality decline in PAH, moving beyond previous studies that relied on subjective questionnaires.
The study's strength lies in its diverse recruitment from multiple sources including the NHLBI-funded L-PVDOMICS program and national patient advocacy groups, creating a representative PAH population. However, the observational design cannot establish causality, and the relatively small longitudinal cohort limits generalizability.
Key Findings
- Daily steps correlated strongly with 6-minute walk distance (r=0.61, p<0.001), validating wearables for functional assessment
- PAH patients averaged 5,200 daily steps at baseline, declining 10.6% to 4,651 steps after one year (p=0.008)
- REM sleep percentage correlated with daily activity levels (r=0.28, p=0.008) in PAH patients
- Sleep quality deteriorated significantly in PAH patients vs matched controls over one year (light sleep p=0.024, REM sleep p=0.034)
- Study included 110 PAH patients at baseline with 44 completing one-year follow-up monitoring
- Cohort was 84% female with median age 52.7 years and predominantly WHO Functional Class II
- Matched control analysis used 132 healthy participants from All of Us Research Program
Methodology
Prospective observational study of 110 PAH patients wearing Fitbit devices for 12 weeks at baseline, with 44 patients completing one-year follow-up. Controls were matched 3:1 from All of Us Research Program using Mahalanobis distance matching on age, sex, BMI, and monitoring dates. Statistical analysis included Spearman correlations, Wilcoxon tests, and generalized least squares models adjusted for demographics.
Study Limitations
Observational design prevents causal inferences about sleep and activity relationships. Relatively small longitudinal cohort (44 patients) may limit generalizability. Participants were unblinded to their activity data, potentially influencing behavior. Study did not reassess 6-minute walk distance or functional class at one-year follow-up.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.